Connect with us
Apart from maintaining bone health and immunity, regular intake of vitamin D is known to reduce the risk of developing serious health complications from COVID-19 and...
The U.S. Food and Drug Administration (FDA) will approve the second bivalent booster this spring after the first dose showed promising results in a recent study....
A new drug could revolutionize the way the medical community handles COVID-19 treatment. On Thursday, a team of scientists presented the findings of their study on...
Research has found that the fourth dose of Pfizer’s COVID-19 vaccine for people aged 60 and above was effective in countering the virus and preventing severe...
As the fourth COVID-19 vaccine dose has started to roll out in more countries, doubts remain on whether or not the extra jab would be necessary....
The third dose of the Pfizer vaccine may provide sufficient protection against omicron and other SARS-CoV-2 variants, but it is not for long term. Research has...
Pharmaceutical giant Pfizer shared promising results Thursday regarding its COVID-19 booster dose for children aged 5 to 11. The company said that an additional shot of...
A third vaccine dose increased antibodies in kids 5 to 11 against the Omicron strain, Pfizer says | Fortune You need to enable JavaScript to view...
Two-dose COVID-19 vaccines provided significant protection against hospitalization and death in people who previously battled an infection with the novel coronavirus before they got jabbed. A...
A study published Wednesday in the New England Journal of Medicine found that a fourth dose of the COVID-19 vaccine is “somewhat efficacious,” but still “immunogenic”...
Recent Comments